|
WO2018094148A1
(en)
|
2016-11-18 |
2018-05-24 |
Arcus Biosciences, Inc. |
Inhibitors of cd73-mediated immunosuppression
|
|
IL269150B2
(en)
|
2017-03-16 |
2025-04-01 |
Innate Pharma |
Cancer treatment preparations and methods
|
|
WO2018208980A1
(en)
|
2017-05-10 |
2018-11-15 |
Oric Pharmaceuticals, Inc. |
Cd73 inhibitors
|
|
BR112020006809A2
(pt)
|
2017-10-06 |
2020-10-06 |
Innate Pharma |
anticorpos, agente, uso, composto, composição farmacêutica, kits e composição ou uso
|
|
US11377469B2
(en)
|
2017-11-03 |
2022-07-05 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
CN112004541A
(zh)
|
2018-03-09 |
2020-11-27 |
艾库斯生物科学有限公司 |
肠道外给药的免疫增强药物
|
|
IL304348B2
(en)
|
2018-04-30 |
2024-08-01 |
Oric Pharmaceuticals Inc |
CD73 inhibitors
|
|
WO2019232319A1
(en)
|
2018-05-31 |
2019-12-05 |
Peloton Therapeutics, Inc. |
Compositions and methods for inhibiting cd73
|
|
DK3807316T3
(da)
|
2018-06-18 |
2024-07-29 |
Innate Pharma |
Sammensætninger og fremgangsmåder til behandling af cancer
|
|
CN112638389A
(zh)
*
|
2018-08-28 |
2021-04-09 |
江苏恒瑞医药股份有限公司 |
Cd73抑制剂及其治疗用途
|
|
MX2021002878A
(es)
|
2018-09-11 |
2021-08-16 |
Risen Suzhou Pharma Tech Co Ltd |
Inhibidores de cd73 y usos farmaceuticos de los mismos.
|
|
US11530234B2
(en)
|
2018-09-11 |
2022-12-20 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
CN110885352B
(zh)
*
|
2018-09-11 |
2023-02-24 |
润佳（苏州）医药科技有限公司 |
Cd73抑制剂及其药学应用
|
|
MX2021008094A
(es)
|
2019-01-11 |
2021-09-21 |
Omeros Corp |
Metodos y composiciones para el tratamiento del cancer.
|
|
CN112955444B
(zh)
*
|
2019-01-22 |
2023-12-12 |
江苏恒瑞医药股份有限公司 |
一种新型的小分子cd73抑制剂、其制备方法及其在医药上的应用
|
|
CN113795267A
(zh)
*
|
2019-03-12 |
2021-12-14 |
艾库斯生物科学有限公司 |
致癌基因驱动的癌症的治疗
|
|
WO2020205527A1
(en)
|
2019-03-29 |
2020-10-08 |
Arcus Biosciences, Inc. |
Treatment of cancer utilizing an identified adenosine fingerprint
|
|
JP7557522B2
(ja)
|
2019-07-16 |
2024-09-27 |
オリック ファーマシューティカルズ，インク． |
Ｃｄ７３阻害剤
|
|
PL4051688T3
(pl)
|
2019-10-30 |
2025-09-22 |
Oric Pharmaceuticals, Inc. |
Inhibitory cd73
|
|
CN119118872A
(zh)
|
2020-03-19 |
2024-12-13 |
艾库斯生物科学有限公司 |
作为HIF-2α抑制剂的四氢化萘和四氢喹啉化合物
|
|
MX2022015157A
(es)
|
2020-06-02 |
2023-01-16 |
Arcus Biosciences Inc |
Anticuerpos para tigit.
|
|
AU2021389685A1
(en)
*
|
2020-11-25 |
2023-07-06 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
Cd73 inhibitors and pharmaceutical uses thereof
|
|
WO2022246179A1
(en)
|
2021-05-21 |
2022-11-24 |
Arcus Biosciences, Inc. |
Axl inhibitor compounds
|
|
EP4341261A1
(en)
|
2021-05-21 |
2024-03-27 |
Arcus Biosciences, Inc. |
Axl compounds
|
|
WO2023077046A1
(en)
|
2021-10-29 |
2023-05-04 |
Arcus Biosciences, Inc. |
Inhibitors of hif-2alpha and methods of use thereof
|
|
JP2025512384A
(ja)
|
2022-04-13 |
2025-04-17 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｔｒｏｐ－２発現がんを治療するための併用療法
|
|
AU2023264591A1
(en)
|
2022-05-02 |
2024-11-07 |
Arcus Biosciences, Inc. |
Anti-tigit antibodies and uses of the same
|
|
JP2025520300A
(ja)
*
|
2022-06-17 |
2025-07-03 |
上海森輝医薬有限公司 |
シクロペンチルアデノシン誘導体及びその医薬的使用
|
|
WO2024015251A1
(en)
|
2022-07-15 |
2024-01-18 |
Arcus Biosciences, Inc. |
Inhibitors of hpk1 and methods of use thereof
|
|
EP4558501A1
(en)
|
2022-07-20 |
2025-05-28 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
CN119768155A
(zh)
|
2022-09-14 |
2025-04-04 |
艾库斯生物科学有限公司 |
依曲地南的分散体
|
|
EP4602041A1
(en)
|
2022-10-14 |
2025-08-20 |
Arcus Biosciences, Inc. |
Hpk1 inhibitors and methods of use thereof
|
|
WO2024233360A1
(en)
|
2023-05-05 |
2024-11-14 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
CN116298323B
(zh)
*
|
2023-05-16 |
2023-08-22 |
南京联笃生物科技有限公司 |
一种用于诊断狼疮性肾炎的生物标志物及应用
|
|
EP4720055A1
(en)
|
2023-05-25 |
2026-04-08 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
WO2025054339A1
(en)
|
2023-09-08 |
2025-03-13 |
Arcus Biosciences, Inc. |
Triazolopyridine compounds as inhibitors of kit
|
|
WO2025072330A1
(en)
|
2023-09-26 |
2025-04-03 |
Arcus Biosciences, Inc. |
Kit inhibitor compounds and methods of use thereof
|
|
US20260116868A1
(en)
|
2023-10-06 |
2026-04-30 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
TW202523302A
(zh)
|
2023-11-02 |
2025-06-16 |
美商阿克思生物科學有限公司 |
噻唑化合物及其使用方法
|
|
WO2025119278A1
(zh)
*
|
2023-12-07 |
2025-06-12 |
无锡和誉生物医药科技有限公司 |
一种cd73抑制剂药物组合物，其制备方法和应用
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025193759A1
(en)
|
2024-03-12 |
2025-09-18 |
Gilead Sciences, Inc. |
Solid forms of an azolopyrimidine compound
|
|
WO2025233264A1
(en)
|
2024-05-07 |
2025-11-13 |
Innate Pharma |
Use of cd73 blocking agents in combination with anti-cd20 x cd3 t cell engagers
|
|
WO2026006759A1
(en)
|
2024-06-28 |
2026-01-02 |
Arcus Biosciences, Inc. |
Pharmaceutical compositions, dosage forms, and methods of making and using same
|